Genmab — Juni 2018
-
-
Fandt lige denne, der ikke passer helt med tidligere info: "The VMP regimen has been studied as initial therapy for multiple myeloma, particularly in elderly patients who are not eligible for HDT-HSCT.2–14 Current guidelines recommend it as a preferred regimen for previously untreated patients who are not eligible for HDT-HSCT"
-
-
Vi lukker i 999
-
nej hvad tænker du på bibob.. Du er langt ved siden af
-
Jeg synes det er tidligt på dagen, at være fuld.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind